Clene Inc. (CLNN) vs Heron Therapeutics, Inc. (HRTX)

Clene Inc. and Heron Therapeutics, Inc. are both Biotechnology companies. Clene Inc. and Heron Therapeutics, Inc. are of similar size ($59.8M and $57.0M). Heron Therapeutics, Inc. grew revenue faster over the last twelve months: 0.99% against −31.1%. Heron Therapeutics, Inc. has the higher net margin (−22.5% vs −20,059.9%) and the lower return on invested capital (−6.35% vs 0.00%). Across the 17 metrics below, Heron Therapeutics, Inc. leads on 13 and Clene Inc. on 4.

Valuation

Metric CLNN HRTX Biotechnology median
P/E n/m n/m 7.88
P/S 270.29 0.38 11.47
P/B n/m 9.75 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 314.15 1.04 10.73
Earnings yield (81.40%) (63.33%) (28.84%)
Free cash flow yield (29.95%) (21.17%) (23.03%)

Profitability

Metric CLNN HRTX Biotechnology median
Gross margin 70.05% 70.07% 65.16%
Operating margin (10,431.98%) (7.19%) 0.00%
Net margin (20,059.90%) (22.52%) 0.00%
Free cash flow margin (8,095.43%) (8.00%) 0.00%
Return on equity 237.15% 318.21% (57.72%)
Return on assets (174.99%) (14.06%) (49.22%)
Return on invested capital 0.00% (6.35%) 0.00%

Growth

Metric CLNN HRTX Biotechnology median
Revenue growth (TTM) (31.12%) 0.99% 5.64%
EPS growth (last fiscal year) 53.26% (33.33%) —
Revenue growth, 5-year CAGR (22.66%) 11.81% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLNN HRTX Biotechnology median
Debt to equity (0.74) 20.65 0.00
Current ratio 3.07 2.49 4.73
Net debt to EBITDA (0.39) (643.88) 0.96

Dividend

Metric CLNN HRTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CLNN HRTX Biotechnology median
Market cap 59.84m 56.96m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack